Longitudinal mapping of a randomized controlled trial of EEG neurofeedback in PTSD: Early symptom stabilization and implications for adjunctive therapeutic potential.
Jonathan M Lieberman, Brendan Brady, Ruth A Lanius et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial investigated the effects of alpha-rhythm EEG neurofeedback on PTSD symptoms in 38 individuals over 20 weeks. The study found that active EEG-NFB led to early stabilization of symptoms, with a significant proportion of participants below the PTSD threshold by week 11. The results highlight the relationship between neural modulation and clinical improvement.
Key findings
- By week 11, a significant proportion of participants were below the probable PTSD threshold.
- Only the experimental group exhibited consistent alpha downregulation during training.
- Greater alpha suppression correlated with improved therapeutic response.
- Diminishing within-session alpha rebound was observed across sessions in the experimental group.
Why it matters
Understanding the neural mechanisms and longitudinal effects of EEG neurofeedback in PTSD can enhance treatment strategies. This research supports the potential of EEG-NFB as an adjunctive therapy, which may improve patient outcomes when integrated with traditional psychotherapy.